Convergence Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53M | Sell |
|
|||||
|
2025
Q1 | $4.65M | Sell |
|
|||||
|
2024
Q4 | $5.12M | Buy |
|
|||||
|
2024
Q3 | $4.33M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $901K | Buy |
|
|||||
|
2023
Q4 | $523K | Buy |
|
|||||
|
2023
Q3 | $530K | Buy |
|
|||||
|
2023
Q2 | $518K | Sell |
|
|||||
|
2023
Q1 | $604K | Sell |
|
|||||
|
2022
Q4 | $635K | Sell |
|
|||||
|
2022
Q3 | $705K | Sell |
|
|||||
|
2022
Q2 | $789K | Buy |
|
|||||
|
2022
Q1 | $626K | Buy |
|
|||||
|
2021
Q4 | $355K | Sell |
|
|||||
|
2021
Q3 | $353K | Buy |
|
|||||
|
2021
Q2 | $335K | Sell |
|
|||||
|
2021
Q1 | $335K | Sell |
|
|||||
|
2020
Q4 | $330K | Sell |
|
|||||
|
2020
Q3 | $322K | Sell |
|
|||||
|
2020
Q2 | $1.28M | Buy |
|
|||||
|
2020
Q1 | $1.1M | Sell |
|
|||||
|
2019
Q4 | $1.93M | Buy |
|
|||||
|
2019
Q3 | $1.06M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $918K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $181K | Sell |
|
|||||
|
2017
Q4 | $4.85M | Buy |
|
|||||
|
2017
Q3 | $4.83M | Sell |
|
|||||
|
2017
Q2 | $4.39M | Buy |
|